Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›
Research›
Non-Profits›
Satio
AddedFeb 17, 2024
UpdatedJun 18, 2026
Satio

Satio

Operating

Satio: Innovating blood collection with simple, painless, and clean patch technology.

Location
Boston, MA, US
Overview
Compare
Employees
Website

Founded with the mission to revolutionize blood collection, Satio focuses on creating simple, painless, and clean patch technology for dried blood spot and whole blood collection. Their innovative products are designed to transform healthcare workflows by offering rapid and affordable detection, prevention, and treatment solutions. Satio primarily targets patients seeking convenient at-home options and those facing challenges in accessing medical services.

Notable figures associated with Satio include key investors and advisors from the healthcare and technology sectors. The company has achieved significant milestones, including the development of patent-pending products that promise to streamline blood collection processes. Although their products are still under review by the FDA and other notified bodies, Satio's impact lies in its potential to make blood collection more accessible and efficient for a broad range of patients.

Satio - Similar Organizations

Matter logo

Matter

Satio - Quick Facts

What organizations are similar to Satio?

Organizations similar to Satio include Matter.

Where is Satio's headquarters located?

Satio's headquarters is located in Boston, MA, US.

When was Satio's last funding round?

Satio's most recent funding round was for $3.5M (USD) in September 2023.

How much has Satio raised to-date?

As of Sep 26, 2023, Satio has raised a total of $3.5M (USD).

How many employees does Satio have?

Satio has 9 employees as of Feb 4, 2024.

Satio - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Blood Collection
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 12 more industry codes
NAICS
  • 622000Hospitals
  • 622100General Medical and Surgical Hospitals
  • 622110General Medical and Surgical Hospitals
  • 813000Religious, Grantmaking, Civic, Professional, and Similar Organizations
  • 813300Social Advocacy Organizations
  • 813310Social Advocacy Organizations
  • 813312Environment, Conservation and Wildlife Organizations
  • 810000Other Services (except Public Administration)
SIC
  • 8060Hospitals
  • 8390Social Services, Not Elsewhere Classified
  • 8300Social Services
  • 8399Social Services, Not Elsewhere Classified